Soft tissue substitute material

Significance of periodontal and peri-implant soft tissue 

Gingival recessions as well as reductions of the mucosa around pontics, dental implants or the reduced width of the keratinized gingiva may have a significant impact not only on the patient’s smile, but also on the long-term prognosis of teeth and implants. 

  • mucoderm®

    Acellular dermal collagen matrix

    Acellular collagen matrix that offers a safe alternative to autologous soft tissue transplants in a diverse range of soft tissue grafting indications.

Valid alternative for the patient’s own tissue

The availability of connective tissue at the donor site is limited, particularly in patients with a thin gingival biotype or if multiple recessions should be treated. Connective tissue harvesting can be associated with an increase in surgery time and patient morbidity and higher risk for post-operative complications. Thus, xenogenic collagen-based materials, such as mucoderm®, are nowadays valid alternatives to autologous grafts to treat soft tissue defects either alone or in combination with a bone augmentation procedure.

Kontakt

Schicken Sie Fragen zu unseren Produkten direkt an unsere Spezialisten:

Produkt Management

Haben Sie Fragen oder Anmerkungen?

Zögern Sie nicht, uns zu kontaktieren!

botiss biomaterials GmbH

Hauptstrasse 28
15806 Zossen / Germany
Tel.: +49 33769 / 88 41 985
Fax: +49 33769 / 88 41 986